Psychiatric medication management for Highland Beach — residential-level optimization, 12 minutes away.

RECO Immersive sits 12 minutes north of Highland Beach on A1A — close enough that families from Bel Lido Isle or Toscana can drop off and stay engaged in weekly family sessions without displacing the rest of life. What the residential setting adds specifically for psychiatric medication management is what a general Boca outpatient practice cannot deliver: observed adherence, weekly lithium and valproate levels drawn on the medically indicated cadence, side effects addressed within twenty-four hours rather than at the next monthly appointment, and a written pharmacology plan that transfers cleanly to the outpatient step-down at RECO Health without losing the residential titration gains.

Highland Beach occupies a narrow oceanfront corridor between Delray and Boca Raton, connected to RECO Immersive’s Delray campus by roughly twelve minutes on A1A. For residents of Bel Lido Isle, Toscana, Boca Cove, or the Penthouse whose depression, PTSD, or bipolar disorder has outrun what a general Boca psychiatry practice can titrate between monthly appointments, the residential program at RECO Immersive delivers what outpatient care structurally cannot: continuous psychiatric presence with observed adherence and lab-driven dose optimization.

What observed adherence and daily monitoring actually change

Outpatient psychiatry runs on self-report. The client says they took the sertraline 100 mg every morning; the prescriber writes that in the note and adjusts on that assumption. When an antidepressant trial fails, the reason is unknowable — was the dose sub-therapeutic, was adherence intermittent, did the client discontinue after the first week of GI side effects and never mention it? In a residential setting, that variable is removed. Medications are administered under observation, timing is documented, and refusal or hesitation is a clinical event that surfaces the same day rather than at the next appointment weeks later.

The distinction matters most for medications with narrow therapeutic windows. Lithium requires trough serum levels between 0.6 and 1.2 mEq/L for maintenance; a single missed dose distorts the picture, and self-reported “I take it most days” is not a dosing regimen. Valproate follows a similar logic. For atypical antipsychotics such as quetiapine, aripiprazole, or olanzapine, adherence is what separates a genuine non-response from a pseudo-non-response driven by intermittent dosing.

Side-effect surveillance changes for the same reason. When a client on a new SNRI develops orthostatic hypotension, insomnia, or activation, it registers within twenty-four hours and the regimen adjusts at the next round rather than at week four when the client has already discontinued and rescheduled.

Comprehensive lab monitoring during the residential stay

Every admission includes a baseline workup: CBC, complete metabolic panel, TSH, B12 and folate, vitamin D, fasting lipid panel, HbA1c, urine drug screen, and urine pregnancy where indicated. The workup is not administrative. Untreated hypothyroidism will masquerade as depression; low B12 will present as cognitive slowing; a positive drug screen will change the medication plan before it is written.

Medication-specific monitoring is built into the residential cadence. Lithium levels are drawn weekly during titration and after any dose change. Valproate levels follow the same rhythm. Atypical antipsychotics generate metabolic panels at admission and again at discharge — weight, fasting glucose, lipids — because the twelve-week metabolic drift on olanzapine or quetiapine is real and clinically actionable. EKG is obtained where QT-prolonging agents or cardiovascular risk factors warrant it. Clozapine, when used, follows its own ANC-monitoring protocol.

The cadence is medically driven. Nothing waits for a scheduling opening — labs get drawn when the pharmacology calls for them.

Coordination with concurrent interventional treatment

A meaningful fraction of Immersive clients are also candidates for interventional treatment through RECO Health — repetitive transcranial magnetic stimulation for treatment-resistant depression, or intranasal esketamine and ketamine infusions for depression with suicidality. When both tracks run in parallel, the medication regimen has to be coordinated with the interventional course rather than negotiated across two independent prescribers.

Standard rTMS courses at 3000 pulses per session at 120% of motor threshold, delivered daily across roughly six weeks, produce the strongest response when the antidepressant floor is stable and adherent through the course. Residential admission is where that stability is easiest to achieve. For esketamine, the medication plan integrates around infusion days — benzodiazepine dosing is reviewed against dissociative signaling, stimulant timing is adjusted, and the post-infusion window is monitored on the unit rather than reconstructed from a phone call.

Ketamine infusions at RECO Health run 0.5 mg/kg over forty minutes, with response assessed against a PHQ-9 or MADRS trajectory across the induction series. Where a residential client is on lamotrigine, an SSRI, or a mood stabilizer at admission, the infusion protocol is designed with the ongoing regimen in mind rather than around it, and clinical response between infusions is documented on the unit rather than at a follow-up call.

Because psychiatry and interventional teams share the chart, response data from TMS or ketamine feeds back into the ongoing pharmacology plan in real time.

The medication plan the client leaves with

Discharge from Immersive includes a written pharmacology plan: current regimen with doses and timing, the rationale for each agent, next-step contingencies if response plateaus, a monitoring schedule, and the specific side effects that warrant a prescriber call. The plan transfers to the RECO Health outpatient team by default, or to a home-community prescriber when the client is stepping back to a private psychiatrist in Boca or Delray.

Continuity is where residential pharmacologic gains are most often lost. A dose optimization that took three weeks of observed titration is undone in a month if the outpatient prescriber does not understand why the client is on 800 mg of quetiapine rather than the previous 300, why buspirone was layered onto the SSRI, or why naltrexone was continued through discharge. The written plan closes that gap. Clients also leave with symptom-scale trajectories — PHQ-9, GAD-7, YBOCS, PCL-5, ASRS where relevant — so the next prescriber can see the delta from admission rather than start from self-report.

What Highland Beach residents should expect at admission

The first twenty-four hours center on assessment. Psychiatric intake covers diagnostic history, prior medication trials with doses and durations, family psychiatric history, trauma history, and current suicidal ideation using structured instruments. A separate substance-use assessment applies ASAM Criteria across the six dimensions where a co-occurring substance disorder is present, and CIWA or COWS protocols initiate if withdrawal management is indicated. Buprenorphine or naltrexone induction begins the same day when opioid or alcohol pharmacotherapy is clinically appropriate.

For clients with adult ADHD presenting alongside depression or substance use, the ASRS is administered at intake and the diagnostic workup separates true attentional pathology from cognitive symptoms secondary to untreated depression, sleep disruption, or stimulant withdrawal — because misdiagnosis in that direction leads to the wrong prescription and unnecessary schedule-II exposure.

Programming layers in over the following forty-eight hours. Individual therapy uses CBT, DBT, EMDR, ACT, or motivational interviewing depending on the presenting problem; groups run daily. The residential milieu is what makes medication adjustment safe at a pace outpatient care cannot match — a new mood stabilizer can be trialed and titrated with vitals, side effects, and behavior all captured on the unit.

Insurance and admissions from Highland Beach

RECO Immersive is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS commercial plans. Admissions verifies benefits before arrival, quantifies deductible and coinsurance for the anticipated length of stay, and confirms whether concurrent RECO Health services — psychiatric medication management, TMS, ketamine — are covered under the same authorization or require separate review.

From Highland Beach the drive is roughly seven miles, twelve minutes north on A1A and then west onto Atlantic Avenue. Families generally handle drop-off themselves; when transportation is a barrier, admissions can coordinate it.

Serving residents of: Bel Lido Isle, Boca Cove, Ocean Cove, Toscana, Penthouse.